INSMED Inc. Files 8-K for Undisclosed Event
Ticker: INSM · Form: 8-K · Filed: 2024-08-09T00:00:00.000Z
Sentiment: neutral
Topics: other-event, sec-filing
TL;DR
INSMED filed an 8-K for an 'Other Event' - details TBD.
AI Summary
On August 9, 2024, INSMED Inc. filed an 8-K report to disclose an "Other Event." The filing does not contain specific details regarding the nature of this event, dollar amounts, or definitive dates beyond the filing date itself. The report was filed with the SEC under the 1934 Act.
Why It Matters
This filing indicates a significant event has occurred for INSMED Inc. that requires immediate disclosure to the public, though the specifics are not yet detailed.
Risk Assessment
Risk Level: medium — The lack of specific information in the 8-K filing creates uncertainty about the nature and potential impact of the 'Other Event' on INSMED Inc.
Key Numbers
- 000-30739 — SEC File Number (Identifies the specific filing for INSMED Inc.)
- 54-1972729 — IRS Employer Identification No. (Tax identification number for INSMED Inc.)
Key Players & Entities
- INSMED Inc. (company) — Registrant
- August 9, 2024 (date) — Filing Date
- Virginia (location) — State of Incorporation
- Bridgewater, New Jersey (location) — Principal Executive Offices
FAQ
What is the specific nature of the 'Other Event' reported by INSMED Inc. on August 9, 2024?
The provided filing excerpt does not specify the nature of the 'Other Event'; it only indicates that an 8-K was filed to report it.
Are there any financial implications associated with this 'Other Event'?
The filing excerpt does not mention any specific dollar amounts or financial implications related to the 'Other Event'.
When did the event that necessitated this 8-K filing occur?
The report is dated August 9, 2024, and is the earliest event reported as of that date.
What is INSMED Inc.'s primary business sector?
INSMED Inc. is in the Pharmaceutical Preparations sector, with SIC code 2834.
Where are INSMED Inc.'s principal executive offices located?
INSMED Inc.'s principal executive offices are located at 700 US Highway 202/206, Bridgewater, New Jersey 08807.
Filing Stats: 492 words · 2 min read · ~2 pages · Grade level 12.6 · Accepted 2024-08-09 17:30:32
Key Financial Figures
- $0.01 — ich registered Common Stock, par value $0.01 per share INSM Nasdaq Global Select
- $198,000 — es in the aggregate principal amount of $198,000 that had not already been converted by
Filing Documents
- ef20033872_8k.htm (8-K) — 24KB
- 0001140361-24-036671.txt ( ) — 155KB
- insm-20240809.xsd (EX-101.SCH) — 4KB
- insm-20240809_lab.xml (EX-101.LAB) — 21KB
- insm-20240809_pre.xml (EX-101.PRE) — 16KB
- ef20033872_8k_htm.xml (XML) — 4KB
01 — Other Events
Item 8.01 — Other Events On August 9, 2024 (the "Redemption Date"), Insmed Incorporated (the "Company") completed its previously announced redemption of all of the aggregate principal amount outstanding of its 1.75% Convertible Senior Notes due 2025 (the "Notes"). Outstanding Notes in the aggregate principal amount of $198,000 that had not already been converted by holders thereof were redeemed for cash at a redemption price equal to 100% of the principal amount of such Notes, plus accrued and unpaid interest on such Notes to, but excluding, the Redemption Date. The redemption was effected pursuant to the terms of the Indenture, dated as of January 26, 2018, as supplemented by the First Supplemental Indenture, dated as of January 26, 2018, between the Company and Computershare Trust Company, National Association, as successor trustee to Wells Fargo Bank, National Association.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: August 9, 2024 INSMED INCORPORATED By: /s/ Michael A. Smith Name: Michael A. Smith Title: Chief Legal Officer and Corporate Secretary